Analyses on Jordan Eshel (5)
- May 28, 2026May 28, 2026
- Follow-up
Eshel Hayarden: Series B Collateral Headroom Depends Too Much on KAVA
Eshel Hayarden's Series B is compliant with its collateral covenant, but the cushion above the threshold is very narrow and depends almost entirely on KAVA surplus that has not yet become released cash.
Eshel Hayarden in the First Quarter: Mavo'ot Dromim Moves Toward Sales, but Cash Still Depends on Project Finance
Eshel Hayarden opened 2026 with positive change at Mavo'ot Dromim: project finance, excavation permits, and binding post-balance-sheet sales. But the improvement has not yet become free cash, and project execution will determine whether 2026 becomes a proof year or another bridg…
- March 30, 2026March 30, 2026
- Follow-up
Follow-up to Eshel Hayarden: How Much of 2025 Earnings Rested on Related Parties
Eshel Hayarden's 2025 earnings base leaned unusually heavily on the related-party and controlling-shareholder circle: roughly three quarters of revenue, a key part of procurement and part of the collection path ran through that same circle, making the year's earnings quality wea…
- Follow-up
Follow-up to Eshel Hayarden: How Much of KAVA's Profit Really Reaches the Listed Issuer
KAVA already proves demand and strong project economics, but the value that is accessible to Eshel Hayarden remains far below the project's 100% numbers because it still has to pass through Diurim, the partner share and lender-controlled release mechanics into at least 2027.
Eshel Hayarden 2025: The Pipeline Is Large, but Financing Still Sets the Pace
Eshel Hayarden is entering a bridge year in which much of the equity has already been invested and the development portfolio is starting to open, but the thesis still depends on Southern Approaches and KAVA turning heavy inventory into financed sales and accessible cash.
More companies in Construction (83)
